Quantum-si Inc income statement
In fiscal 2025, Quantum-si Inc reported revenue of $2.4m, down 20.3% on the year before, operating income of −$116m (a -4766.0% margin) and net income of −$101m, or −$0.51 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 | 3 | 2 | 2 |
| Cost of revenue | 0 | 0 | 1 | 1 | 1 | 1 |
| Gross profit | 0 | 0 | 0 | 2 | 1 | 1 |
| Research and development | 47 | 72 | 67 | 60 | 54 | 55 |
| Selling, general and administrative | 50 | 42 | 45 | 51 | 45 | 41 |
| Operating income | −97 | −124 | −111 | −109 | −116 | −111 |
| Interest expense | 0 | 0 | — | — | — | — |
| Net interest income | −0 | 0 | 0 | — | — | — |
| Income before tax | −95 | −132 | −96 | −101 | −101 | −99 |
| Income tax | 0 | 0 | 0 | 0 | 0 | −0 |
| Net income | −95 | −132 | −96 | −101 | −101 | −99 |
| Diluted EPS | −$1.19 | −$0.95 | −$0.68 | −$0.71 | −$0.51 | −$0.46 |
| Diluted shares (average) | 80m | 139m | 141m | 143m | 198m | 215m |
| EBITDA | −96 | −121 | −107 | −104 | −112 | −106 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Cost of revenue | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 16 | 17 | 14 | 15 | 14 | 11 | 14 | 16 |
| Selling, general and administrative | 12 | 14 | 12 | 12 | 11 | 10 | 10 | 10 |
| Operating income | −28 | −31 | −25 | −30 | −40 | −21 | −24 | −26 |
| Income before tax | −25 | −33 | −19 | −29 | −36 | −18 | −22 | −24 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 |
| Net income | −25 | −33 | −19 | −29 | −36 | −18 | −22 | −24 |
| Diluted EPS | −$0.18 | −$0.23 | −$0.11 | −$0.16 | −$0.17 | −$0.07 | −$0.10 | −$0.11 |
| EBITDA | −27 | −30 | −24 | −29 | −39 | −20 | −23 | −24 |
Compare with peers
- Bionexus Gene Lab Corp income statement
- YD Bio Ltd income statement
- Ispecimen Inc. income statement
- Seer, Inc. income statement
- Bionano Genomics, Inc. income statement
Head to head: BGLC vs QSIQSI vs YDESISPC vs QSI
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies